Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) is a publicly traded company in the Healthcare sector, operating within the Medical - Pharmaceuticals industry. The company is headquartered in Nashville, DE, United States. The current CEO is Mark L. Baum.
HROWL has IPO date of 2021-05-07, 217 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $1.37B.
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
